{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:47Z","timestamp":1791821027899,"version":"4.3.4"},"reference-count":240,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB736"],"award-info":[{"award-number":["2023AFB736"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tox.2025.154359","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:01:46Z","timestamp":1764172906000},"page":"154359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Advances in antituberculosis drug-induced liver injury: Molecular mechanisms, genetic insights, and emerging animal-free prediction models"],"prefix":"10.1016","volume":"520","author":[{"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2025.154359_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12879-017-2330-z","article-title":"Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK","volume":"17","author":"Abbara","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.tox.2025.154359_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10616-020-00384-w","article-title":"Genome-wide expression profiling reveals increased stability and mitochondrial energy metabolism of the human liver cell line HepaRG-CAR","volume":"72","author":"Adam","year":"2020","journal-title":"Cytotechnology"},{"key":"10.1016\/j.tox.2025.154359_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193664","article-title":"A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines","volume":"13","author":"Adam","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2025.154359_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03639","article-title":"Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents","volume":"6","author":"Adeniji","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.tox.2025.154359_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112215","article-title":"Epiphytic Acampe ochracea orchid relieves paracetamol-induced hepatotoxicity by inhibiting oxidative stress and upregulating antioxidant genes in in vivo and virtual screening","volume":"143","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00228-018-2448-y","article-title":"N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians","volume":"74","author":"Aklillu","year":"2018","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030855","article-title":"Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions","volume":"19","author":"Alam","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/1568026620666201204155830","article-title":"Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies","volume":"21","author":"Alam","year":"2021","journal-title":"Curr. Top. Med Chem."},{"key":"10.1016\/j.tox.2025.154359_bib9","article-title":"Multifactorial Effects of Gelling Conditions on Mechanical Properties of Skin-Like Gelatin Membranes Intended for In Vitro Experimentation and Artificial Skin Models","volume":"13","author":"Alarc\u00f3n-Segovia","year":"2021","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.tox.2025.154359_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5582\/ddt.2020.03029","article-title":"Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India","volume":"14","author":"Ali","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/acs.chemrestox.2c00343","article-title":"Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System","volume":"36","author":"Ali","year":"2023","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/gut.2006.097576","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"83","author":"Anstey","year":"2007","journal-title":"Post. Med J."},{"key":"10.1016\/j.tox.2025.154359_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.tiv.2012.05.008","article-title":"Optimization of the HepaRG cell model for drug metabolism and toxicity studies","volume":"26","author":"Anth\u00e9rieu","year":"2012","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2025.154359_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23386","article-title":"Molecular and cellular remodeling of HepG2 cells upon treatment with antitubercular drugs","volume":"37","author":"Bakshi","year":"2023","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12906-024-04685-x","article-title":"Herbo-vitamin medicine Livogrit Vital ameliorates isoniazid induced liver injury (IILI) in human liver (HepG2) cells by decreasing isoniazid accumulation and oxidative stress driven hepatotoxicity","volume":"24","author":"Balkrishna","year":"2024","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.tox.2025.154359_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40495-018-0131-8","article-title":"Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury","volume":"4","author":"Bao","year":"2018","journal-title":"Curr. Pharm. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib17","doi-asserted-by":"crossref","first-page":"37134","DOI":"10.1039\/D0RA06478E","article-title":"Multicomponent crystals of anti-tuberculosis drugs: a mini-review","volume":"10","author":"Batisai","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.tox.2025.154359_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib19","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s13346-023-01327-6","article-title":"Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review","volume":"13","author":"Biju","year":"2023","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.tox.2025.154359_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pneumo.2013.10.004","article-title":"The \"DRESS\" syndrome in antituberculosis drugs","volume":"70","author":"Bopaka","year":"2014","journal-title":"Rev. Pneumol. Clin."},{"key":"10.1016\/j.tox.2025.154359_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114316","article-title":"Conducting bioinformatics analysis to predict sulforaphane-triggered adverse outcome pathways in healthy human cells","volume":"160","author":"Bozic","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kfy294","article-title":"The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis","volume":"168","author":"Brewer","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10409238.2011.624491","article-title":"Proteomics and pluripotency","volume":"46","author":"Brumbaugh","year":"2011","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"key":"10.1016\/j.tox.2025.154359_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials","volume":"13","author":"Bucher","year":"1999","journal-title":"Aids"},{"key":"10.1016\/j.tox.2025.154359_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047769","article-title":"Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"7","author":"Cai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2025.154359_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2018.02.030","article-title":"First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform","volume":"497","author":"Cao","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.tox.2025.154359_bib27","doi-asserted-by":"crossref","first-page":"47536","DOI":"10.1021\/acsomega.2c05693","article-title":"Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point","volume":"7","author":"Cavasotto","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.tox.2025.154359_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad161","article-title":"Standardized In Vitro Models of Human Adipose Tissue Reveal Metabolic Flexibility in Brown Adipocyte Thermogenesis","volume":"164","author":"Cero","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2025.154359_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.phymed.2017.09.016","article-title":"Modulation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation by ursolic acid (UA) attenuates rifampin-isoniazid cytotoxicity","volume":"36","author":"Chang","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tox.2025.154359_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115799","article-title":"Smartphone-assisted fluorescence-based detection of sunrise-type smart amplification process and a 3D-printed ultraviolet light-emitting diode device for the diagnosis of tuberculosis","volume":"244","author":"Chen","year":"2024","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.tox.2025.154359_bib31","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1080\/21655979.2021.2024970","article-title":"4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.tox.2025.154359_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/bmm.13.146","article-title":"Toward predictive models for drug-induced liver injury in humans: are we there yet?","volume":"8","author":"Chen","year":"2014","journal-title":"Biomark. Med"},{"key":"10.1016\/j.tox.2025.154359_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kft189","article-title":"Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs","volume":"136","author":"Chen","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib34","article-title":"Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5044451","article-title":"Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis","volume":"2023","author":"Chen","year":"2023","journal-title":"J. Trop. Med"},{"key":"10.1016\/j.tox.2025.154359_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mib.2021.11.014","article-title":"Animal models in vaccinology: state of the art and future perspectives for an animal-free approach","volume":"66","author":"Chiarot","year":"2022","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1016\/j.tox.2025.154359_bib37","article-title":"Flow-Based Three-Dimensional Co-Culture Model for Long-Term Hepatotoxicity Prediction","volume":"11","author":"Choi","year":"2019","journal-title":"Micro (Basel)"},{"key":"10.1016\/j.tox.2025.154359_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jmii.2014.08.006","article-title":"Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan","volume":"49","author":"Chou","year":"2016","journal-title":"J. Microbiol Immunol. Infect."},{"key":"10.1016\/j.tox.2025.154359_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhep.2006.01.027","article-title":"Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice","volume":"45","author":"Chowdhury","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.134297","article-title":"Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity","volume":"471","author":"Chung","year":"2024","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.tox.2025.154359_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03262213","article-title":"Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs","volume":"16","author":"Costa","year":"2012","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cod.13296","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature","volume":"81","author":"Coster","year":"2019","journal-title":"Contact Dermat."},{"key":"10.1016\/j.tox.2025.154359_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10822-013-9648-4","article-title":"QSAR workbench: automating QSAR modeling to drive compound design","volume":"27","author":"Cox","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.tox.2025.154359_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114666","article-title":"Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG\u00ae cells","volume":"379","author":"Cuykx","year":"2019","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70138","article-title":"Natural History of Idiosyncratic Drug-Induced Liver Injury and Prognostic Models","volume":"45","author":"Devarbhavi","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.tox.2025.154359_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1208\/s12248-020-00527-z","article-title":"Correction to: In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes","volume":"22","author":"Docci","year":"2020","journal-title":"Aaps J."},{"key":"10.1016\/j.tox.2025.154359_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911428","article-title":"In Vitro Models for Studying Chronic Drug-Induced Liver Injury","volume":"23","author":"Donato","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.6026\/97320630007082","article-title":"2D-QSAR model development and analysis on variant groups of anti-tuberculosis drugs","volume":"7","author":"Dwivedi","year":"2011","journal-title":"Bioinformation"},{"key":"10.1016\/j.tox.2025.154359_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69228-z","article-title":"Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics","volume":"10","author":"Dyavar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112819","article-title":"Functional Recellularization of Acellular Rat Liver Scaffold by Induced Pluripotent Stem Cells: Molecular Evidence for Wnt\/B-Catenin Upregulation","volume":"10","author":"Ebrahim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tox.2025.154359_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/toxsci\/kft134","article-title":"Hepatocyte growth factor protects against isoniazid\/rifampicin-induced oxidative liver damage","volume":"135","author":"Enriquez-Cortina","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.tox.2025.154359_bib53","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.30582","article-title":"Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis","volume":"237","author":"Ezhilarasan","year":"2022","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.tox.2025.154359_bib55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/03602532.2023.2215478","article-title":"Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms","volume":"55","author":"Ezhilarasan","year":"2023","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2025.154359_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int"},{"key":"10.1016\/j.tox.2025.154359_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00204-020-02668-8","article-title":"Enhanced activation of human NK cells by drug-exposed hepatocytes","volume":"94","author":"Fasbender","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/cei.12558","article-title":"Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis","volume":"180","author":"Foureau","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2025.154359_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041300","article-title":"Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery","volume":"15","author":"Fu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tox.2025.154359_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.652704","article-title":"Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity","volume":"12","author":"Fukunaga","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.tox.2025.154359_bib61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10565-017-9383-z","article-title":"A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines","volume":"33","author":"Gao","year":"2017","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib62","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/C6TX00101G","article-title":"Characterization of a functional C3A liver spheroid model","volume":"5","author":"Gaskell","year":"2016","journal-title":"Toxicol. Res (Camb. )"},{"key":"10.1016\/j.tox.2025.154359_bib63","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2174\/0929867330666230207112539","article-title":"Berberine: Pharmacological Features in Health, Disease and Aging","volume":"31","author":"Gasmi","year":"2024","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.tox.2025.154359_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2017.10.003","article-title":"Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing","volume":"268","author":"Genina","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.tox.2025.154359_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2165\/00003495-198223010-00003","article-title":"Adverse effects of antituberculosis drugs","volume":"23","author":"Girling","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.tox.2025.154359_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0253-7613.174519","article-title":"Evaluation of cytochrome P4502E1 polymorphisms in healthy adult Western Indians and patients with antituberculous drug-induced hepatotoxicity","volume":"48","author":"Gogtay","year":"2016","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib67","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","article-title":"Competency of different cell models to predict human hepatotoxic drugs","volume":"10","author":"G\u00f3mez-Lech\u00f3n","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41575-020-00386-1","article-title":"Human biomimetic liver microphysiology systems in drug development and precision medicine","volume":"18","author":"Gough","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxrep.2017.02.001","article-title":"Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study","volume":"4","author":"Granitzny","year":"2017","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/srep21868","article-title":"Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model","volume":"6","author":"Gr\u00f6ger","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib71","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/bmj.292.6524.866","article-title":"Cholestatic jaundice caused by ethambutol","volume":"292","author":"Gulliford","year":"1986","journal-title":"Br. Med J. (Clin. Res Ed."},{"key":"10.1016\/j.tox.2025.154359_bib72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2017.01.002","article-title":"Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2\u03b1-ATF4-CHOP pathway","volume":"378","author":"Guo","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154359_bib73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2025.154359_bib75","first-page":"1952","article-title":"Review of machine learning and deep learning models for toxicity prediction","volume":"248","author":"Guo","year":"2023","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.tox.2025.154359_bib76","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jgh.12194","article-title":"Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India","volume":"28","author":"Gupta","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib78","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7150\/ijbs.85145","article-title":"Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases","volume":"19","author":"Han","year":"2023","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib79","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/cpt.1871","article-title":"Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity","volume":"108","author":"Hassani-Nezhad-Gashti","year":"2020","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib80","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","article-title":"Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling","volume":"12","author":"He","year":"2021","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.tox.2025.154359_bib81","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s42242-021-00137-4","article-title":"Biofabrication of size-controlled liver microtissues incorporated with ECM-derived microparticles to prolong hepatocyte function","volume":"4","author":"Heydari","year":"2021","journal-title":"BioDes. Manuf."},{"key":"10.1016\/j.tox.2025.154359_bib82","article-title":"NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis","volume":"13","author":"Higuchi","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2025.154359_bib83","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-198409060-00003","article-title":"Clinical pharmacokinetics of the antituberculosis drugs","volume":"9","author":"Holdiness","year":"1984","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpharm.2017.11.016","article-title":"3D printed UV light cured polydimethylsiloxane devices for drug delivery","volume":"544","author":"Holl\u00e4nder","year":"2018","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib85","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.02278-13","article-title":"Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein","volume":"58","author":"Horita","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1022809","article-title":"Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury","volume":"13","author":"Hou","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.fct.2015.01.020","article-title":"Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines","volume":"78","author":"Huang","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib88","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib89","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/dmd.121.000389","article-title":"Metabolism and Hepatotoxicity of Pyrazinamide, an Antituberculosis Drug","volume":"49","author":"Hussain","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2025.154359_bib90","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/cts.13281","article-title":"A literature review of liver function test elevations in rifampin drug-drug interaction studies","volume":"15","author":"Ibrahim","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib91","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2131\/jts.37.373","article-title":"Development of humanized steroid and xenobiotic receptor mouse by homologous knock-in of the human steroid and xenobiotic receptor ligand binding domain sequence","volume":"37","author":"Igarashi","year":"2012","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17425255.2024.2328794","article-title":"Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety","volume":"20","author":"Jadalannagari","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib93","first-page":"753","article-title":"PRINTING TECHNIQUES: RECENT DEVELOPMENTS IN PHARMACEUTICAL TECHNOLOGY","volume":"74","author":"Jamroz","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib94","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/term.2802","article-title":"Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip","volume":"13","author":"Jang","year":"2019","journal-title":"J. Tissue Eng. Regen. Med"},{"key":"10.1016\/j.tox.2025.154359_bib95","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cpt.2887","article-title":"3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction","volume":"113","author":"J\u00e4rvinen","year":"2023","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib96","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-137-8-200210150-00007","article-title":"Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial","volume":"137","author":"Jasmer","year":"2002","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.tox.2025.154359_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103499","article-title":"QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL(pro) Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches","volume":"15","author":"Jawarkar","year":"2022","journal-title":"Arab J. Chem."},{"key":"10.1016\/j.tox.2025.154359_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062954","article-title":"Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges","volume":"22","author":"Jee","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.129193","article-title":"Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay","volume":"436","author":"Jia","year":"2022","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.tox.2025.154359_bib100","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/liv.14896","article-title":"Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients","volume":"41","author":"Jiang","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.tox.2025.154359_bib101","article-title":"Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK\/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910214","article-title":"Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro","volume":"22","author":"Kammerer","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib103","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180845","article-title":"Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence","volume":"39","author":"Khan","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib104","article-title":"HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea","volume":"13","author":"Kim","year":"2024","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.tox.2025.154359_bib105","article-title":"Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice","volume":"18","author":"Kim","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib106","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4168\/aair.2015.7.1.88","article-title":"Superoxide Dismutase Gene (SOD1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis","volume":"7","author":"Kim","year":"2015","journal-title":"Allergy Asthma Immunol. Res"},{"key":"10.1016\/j.tox.2025.154359_bib107","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12879-016-1344-2","article-title":"Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.tox.2025.154359_bib108","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.csbj.2021.06.034","article-title":"Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis","volume":"19","author":"Kingdon","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tox.2025.154359_bib109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature01254","article-title":"Computational systems biology","volume":"420","author":"Kitano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tox.2025.154359_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030388","article-title":"Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective","volume":"16","author":"Kivrane","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tox.2025.154359_bib111","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/mol.119.117333","article-title":"CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor\/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis","volume":"96","author":"Kobayashi","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.dmpk.2020.03.001","article-title":"Comparison of the inducibility of CYP mRNA exposed to typical inducers in fresh and cryopreserved cynomolgus monkey hepatocytes","volume":"35","author":"Koeda","year":"2020","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/105221620X15868728381608","article-title":"Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models","volume":"20","author":"Kukla","year":"2020","journal-title":"Gene Expr."},{"key":"10.1016\/j.tox.2025.154359_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12664-024-01643-w","article-title":"Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis","volume":"44","author":"Kumar","year":"2025","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.tox.2025.154359_bib115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcp.2018.06.026","article-title":"Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines","volume":"155","author":"Kvist","year":"2018","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2019.105307","article-title":"Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques","volume":"188","author":"Lai","year":"2020","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.tox.2025.154359_bib117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13619-021-00089-1","article-title":"Emerging liver organoid platforms and technologies","volume":"10","author":"Lam","year":"2021","journal-title":"Cell Regen."},{"key":"10.1016\/j.tox.2025.154359_bib118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-62703-321-3_25","article-title":"Highly efficient SiRNA and gene transfer into hepatocyte-like HepaRG cells and primary human hepatocytes: new means for drug metabolism and toxicity studies","volume":"987","author":"Laurent","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2025.154359_bib119","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J. Korean Med Sci."},{"key":"10.1016\/j.tox.2025.154359_bib120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","article-title":"Three-dimensional HepaRG model as an attractive tool for toxicity testing","volume":"130","author":"Leite","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.661075","article-title":"Prediction of Alternative Drug-Induced Liver Injury Classifications Using Molecular Descriptors, Gene Expression Perturbation, and Toxicology Reports","volume":"12","author":"Lesi\u0144ski","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.tox.2025.154359_bib122","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm.3104","article-title":"Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy","volume":"19","author":"Li","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.tox.2025.154359_bib123","first-page":"75","article-title":"SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury","volume":"6","author":"Li","year":"2012","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.tox.2025.154359_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110502","article-title":"ROS and DRP1 interactions accelerate the mitochondrial injury induced by polystyrene nanoplastics in human liver HepG2 cells","volume":"379","author":"Li","year":"2023","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.tox.2025.154359_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074866","article-title":"Anti-tuberculosis drug-induced liver injury","volume":"383","author":"Lim","year":"2023","journal-title":"Bmj"},{"key":"10.1016\/j.tox.2025.154359_bib126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfac075","article-title":"Machine Learning and Artificial Intelligence in Toxicological Sciences","volume":"189","author":"Lin","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib127","article-title":"Dissecting Acute Drug-Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver-On-A-Chip Model","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.tox.2025.154359_bib128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13619-025-00226-0","article-title":"Standard: human liver-on-a-chip","volume":"14","author":"Liu","year":"2025","journal-title":"Cell Regen."},{"key":"10.1016\/j.tox.2025.154359_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12938-024-01226-y","article-title":"Construction of in vitro liver-on-a-chip models and application progress","volume":"23","author":"Liu","year":"2024","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.tox.2025.154359_bib130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2133\/dmpk.DMPK-13-NT-089","article-title":"Role of CYP3A in isoniazid metabolism in vivo","volume":"29","author":"Liu","year":"2014","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib131","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221097365","article-title":"Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump","volume":"41","author":"Liu","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bcp.16228","article-title":"Clinical characteristics and risk factors for antituberculosis drug-induced hypersensitivity","volume":"91","author":"Liu","year":"2025","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib133","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/ ."},{"key":"10.1016\/j.tox.2025.154359_bib134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro","volume":"63","author":"L\u00fcbberstedt","year":"2011","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.tox.2025.154359_bib135","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.analchem.5b03869","article-title":"On-Chip Construction of Liver Lobule-like Microtissue and Its Application for Adverse Drug Reaction Assay","volume":"88","author":"Ma","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tox.2025.154359_bib136","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12874-024-02443-8","article-title":"Efficient analysis of drug interactions in liver injury: a retrospective study leveraging natural language processing and machine learning","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Med Res Method."},{"key":"10.1016\/j.tox.2025.154359_bib137","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13577-017-0175-9","article-title":"Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance","volume":"30","author":"Mann","year":"2017","journal-title":"Hum. Cell"},{"key":"10.1016\/j.tox.2025.154359_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102246","article-title":"Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing","volume":"136","author":"Masiphephethu","year":"2022","journal-title":"Tuberc. (Edinb. )"},{"issue":"4","key":"10.1016\/j.tox.2025.154359_bib139","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/adhm.201200299","article-title":"Three-dimensional human tissue chips fabricated by rapid and automatic inkjet cell printing","volume":"2","author":"Matsusaki","year":"2013","journal-title":"Adv. Healthc Mater."},{"key":"10.1016\/j.tox.2025.154359_bib140","article-title":"Liver-on-chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tox.2025.154359_bib141","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s11033-022-08158-7","article-title":"Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury","volume":"50","author":"Meitei","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aivt.2017.0022","article-title":"Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues","volume":"4","author":"Messner","year":"2018","journal-title":"Appl. Vitr. Toxicol."},{"issue":"6","key":"10.1016\/j.tox.2025.154359_bib143","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib144","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/clpt.2010.355","article-title":"A fresh look at the mechanism of isoniazid-induced hepatotoxicity","volume":"89","author":"Metushi","year":"2011","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/tx500013z","article-title":"Mild isoniazid-induced liver injury in humans is associated with an increase in Th17 cells and T cells producing IL-10","volume":"27","author":"Metushi","year":"2014","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib146","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.freeradbiomed.2009.05.018","article-title":"Regulation of superoxide dismutase genes: implications in disease","volume":"47","author":"Miao","year":"2009","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.tox.2025.154359_bib147","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","article-title":"Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis","volume":"84","author":"Mitchell","year":"1976","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.tox.2025.154359_bib148","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11030-022-10511-8","article-title":"Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies","volume":"27","author":"Modi","year":"2023","journal-title":"Mol. Divers"},{"key":"10.1016\/j.tox.2025.154359_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47010007","article-title":"Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects","volume":"47","author":"Nair","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.tox.2025.154359_bib150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1126\/science.7838","article-title":"Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat","volume":"193","author":"Nelson","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.tox.2025.154359_bib151","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/cpt.2100","article-title":"Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens","volume":"109","author":"Nicoletti","year":"2021","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib152","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.2174\/1381612819666131118165059","article-title":"Recent advances in QSAR-based identification and design of anti-tubercular agents","volume":"20","author":"Nidhi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tox.2025.154359_bib153","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.123.001441","article-title":"Evaluating Drug-Drug Interaction Risk Associated with Peptide Analogs Using advanced In Vitro Systems","volume":"52","author":"N\u00f8rgaard","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2025.154359_bib154","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1208\/s12249-018-1233-7","article-title":"3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release","volume":"20","author":"\u00d6blom","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.tox.2025.154359_bib155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00204-020-02882-4","article-title":"An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury","volume":"95","author":"Oda","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib156","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/toxsci\/kfx069","article-title":"Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells","volume":"158","author":"Ogese","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib157","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.30701","article-title":"Exosomal Transport of Hepatocyte-Derived Drug-Modified Proteins to the Immune System","volume":"70","author":"Ogese","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2025.154359_bib158","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1067\/mcp.2002.126175","article-title":"Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients","volume":"72","author":"Ohkawa","year":"2002","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3069","article-title":"A functional long-term 2D serum-free human hepatic in vitro system for drug evaluation","volume":"37","author":"Oleaga","year":"2021","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.tox.2025.154359_bib160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5588\/ijtld.12.0441","article-title":"Difficult clinical management of anti-tuberculosis DRESS syndrome","volume":"17","author":"Palmero","year":"2013","journal-title":"Int J. Tube Lung Dis."},{"key":"10.1016\/j.tox.2025.154359_bib161","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1186\/s12864-016-3078-3","article-title":"Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity","volume":"17","author":"Petros","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.tox.2025.154359_bib162","first-page":"474","article-title":"Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study","volume":"48","author":"Pourmohamadi","year":"2023","journal-title":"Iran. J. Med Sci."},{"key":"10.1016\/j.tox.2025.154359_bib163","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2023.04.010","article-title":"Molecular mechanism for the activation of the potent hepatotoxin acetylhydrazine: Identification of the initial N-centered radical and the secondary C-centered radical intermediates","volume":"204","author":"Qin","year":"2023","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.tox.2025.154359_bib164","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/bpb.b18-00028","article-title":"Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1\/FXR Pathway in Rats and HepG2 Cells","volume":"41","author":"Qu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tox.2025.154359_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46193-x","article-title":"Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations","volume":"13","author":"Rafiq","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib166","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib167","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.2705","article-title":"PharmVar GeneFocus: SLCO1B1","volume":"113","author":"Ramsey","year":"2023","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib168","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0960327117705426","article-title":"Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid","volume":"37","author":"Rawat","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib169","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","article-title":"A microfluidically perfused three dimensional human liver model","volume":"71","author":"Rennert","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.tox.2025.154359_bib170","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2025.154359_bib171","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/toxsci\/kfh232","article-title":"Hepatic gene expression and lipid homeostasis in C57BL\/6 mice exposed to hydrazine or acetylhydrazine","volume":"82","author":"Richards","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib172","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01776-16","article-title":"Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro","volume":"61","author":"Roberts","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib173","doi-asserted-by":"crossref","first-page":"24387","DOI":"10.1038\/s41598-024-73918-3","article-title":"Exploring the properties of antituberculosis drugs through QSPR graph models and domination-based topological descriptors","volume":"14","author":"S","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154359_bib174","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002040050347","article-title":"Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits","volume":"70","author":"Sarich","year":"1996","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib175","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1124\/dmd.115.063495","article-title":"Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor","volume":"43","author":"Sarkar","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2025.154359_bib176","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.tox.2025.154359_bib177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021836","article-title":"Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China","volume":"6","author":"Shang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2025.154359_bib178","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1164\/rccm.2108091","article-title":"Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment","volume":"166","author":"Sharma","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.tox.2025.154359_bib179","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and Etiology of Drug-Induced Liver Injury in Mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2025.154359_bib180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.meegid.2014.01.034","article-title":"The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis","volume":"24","author":"Sheng","year":"2014","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.tox.2025.154359_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/biom14081019","article-title":"The Prospect of Hepatic Decellularized Extracellular Matrix as a Bioink for Liver 3D Bioprinting","volume":"14","author":"Shi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.tox.2025.154359_bib182","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/AAC.01866-12","article-title":"A novel mechanism underlies the hepatotoxicity of pyrazinamide","volume":"57","author":"Shih","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib183","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2025.154359_bib184","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.euf.2019.04.011","article-title":"Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management","volume":"5","author":"Silagy","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.tox.2025.154359_bib185","article-title":"Lessons and updates from India's National Tuberculosis Elimination Program - bold decisions and innovative ways of fast-tracking progress toward ending tuberculosis","volume":"14","author":"Singh","year":"2025","journal-title":"IJID Reg."},{"key":"10.1016\/j.tox.2025.154359_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116500","article-title":"Rifampicin and its derivatives: stability, disposition, and affinity towards pregnane X receptor employing 2D and 3D primary human hepatocytes","volume":"229","author":"Smutny","year":"2024","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib187","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.xphs.2017.10.021","article-title":"Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability","volume":"107","author":"Solanki","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib188","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ebiom.2016.02.040","article-title":"A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies","volume":"6","author":"Srivastava","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tox.2025.154359_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.143255","article-title":"Hepatocellular carcinoma (HepG2\/C3A) cell-based 3D model for genotoxicity testing of chemicals","volume":"755","author":"\u0160tampar","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.tox.2025.154359_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111476","article-title":"Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI","volume":"12","author":"Stern","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tox.2025.154359_bib191","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8086253","article-title":"Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes","volume":"2021","author":"Su","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.tox.2025.154359_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153829","article-title":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","volume":"505","author":"Sun","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154359_bib193","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02692-18","article-title":"Genomewide Association Study Confirming the Association of NAT2 with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients","volume":"63","author":"Suvichapanich","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib194","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1089\/omi.2019.0122","article-title":"MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications","volume":"23","author":"Swart","year":"2019","journal-title":"Omics"},{"key":"10.1016\/j.tox.2025.154359_bib195","doi-asserted-by":"crossref","first-page":"13953","DOI":"10.1074\/jbc.M312170200","article-title":"Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome p450 overproduction","volume":"279","author":"Szczesna-Skorupa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2025.154359_bib196","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.tox.2025.154359_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.845360","article-title":"Applied Hepatic Bioengineering: Modeling the Human Liver Using Organoid and Liver-on-a-Chip Technologies","volume":"10","author":"Telles-Silva","year":"2022","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.tox.2025.154359_bib198","doi-asserted-by":"crossref","DOI":"10.3390\/toxics11050419","article-title":"The System of Self-Consistent Models: QSAR Analysis of Drug-Induced Liver Toxicity","volume":"11","author":"Toropova","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.tox.2025.154359_bib199","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tox.2025.154359_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1332752","article-title":"Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships","volume":"15","author":"Ulanova","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/toxsci\/kfw218","article-title":"From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury","volume":"155","author":"Usui","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154359_bib203","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/acs.chemrestox.6b00393","article-title":"Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury","volume":"29","author":"Usui","year":"2016","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib204","article-title":"A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing","author":"Verma","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.tox.2025.154359_bib205","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","article-title":"Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents","volume":"155","author":"Villarino","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.tox.2025.154359_bib206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA no longer has to require animal testing for new drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tox.2025.154359_bib207","article-title":"Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib208","article-title":"Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.tox.2025.154359_bib209","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","article-title":"Isoniazid metabolism and hepatotoxicity","volume":"6","author":"Wang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tox.2025.154359_bib210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5588\/ijtld.11.0377","article-title":"NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"16","author":"Wang","year":"2012","journal-title":"Int J. Tube Lung Dis."},{"key":"10.1016\/j.tox.2025.154359_bib211","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1210\/en.2005-1485","article-title":"The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2025.154359_bib212","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tox.2025.154359_bib213","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1039\/C8LC00869H","article-title":"In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system","volume":"18","author":"Wang","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.tox.2025.154359_bib214","article-title":"Pyrazinamide related prolonged drug-induced liver injury: A case report","volume":"101","author":"Wang","year":"2022","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.tox.2025.154359_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109010","article-title":"A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro","volume":"116","author":"Wang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib216","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/17410541.4.2.123","article-title":"NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patients","volume":"4","author":"Werely","year":"2007","journal-title":"Per Med"},{"key":"10.1016\/j.tox.2025.154359_bib217","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1139\/y83-073","article-title":"Isoniazid-induced hepatic steatosis in rabbits: an explanation for susceptibility and its antagonism by pyridoxine hydrochloride","volume":"61","author":"Whitehouse","year":"1983","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib218","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1547691X.2016.1254305","article-title":"Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response","volume":"14","author":"Whritenour","year":"2017","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.tox.2025.154359_bib219","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0004-2015","article-title":"Animal Models of Tuberculosis: An Overview","volume":"4","author":"Williams","year":"2016","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.tox.2025.154359_bib220","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01124-13","article-title":"Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine","volume":"57","author":"Williamson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2025.154359_bib221","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1767421","article-title":"Mechanism of Salvia miltiorrhiza Bge. for the Treatment of Ischemic Stroke Based on Bioinformatics and Network Pharmacology","volume":"2022","author":"Wu","year":"2022","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.tox.2025.154359_bib222","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/acs.jcim.6b00719","article-title":"Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury","volume":"57","author":"Wu","year":"2017","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.tox.2025.154359_bib223","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3121","article-title":"A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population","volume":"21","author":"Wu","year":"2019","journal-title":"J. Gene Med"},{"key":"10.1016\/j.tox.2025.154359_bib224","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/aps.2014.102","article-title":"Deciphering the roles of the constitutive androstane receptor in energy metabolism","volume":"36","author":"Yan","year":"2015","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.tox.2025.154359_bib225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027940","article-title":"Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.tox.2025.154359_bib226","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/0960327120979030","article-title":"Tanshinone \u2161A may alleviate rifampin-induced cholestasis by regulating the expression and function of NTCP","volume":"40","author":"Yang","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2025.154359_bib227","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/bjd.14839","article-title":"Drug-specific CD4(+) T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome","volume":"176","author":"Ye","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2025.154359_bib228","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.tox.2025.154359_bib229","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s12276-024-01172-8","article-title":"Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity","volume":"56","author":"Yoon","year":"2024","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.tox.2025.154359_bib230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/DDDT.S495555","article-title":"Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model","volume":"19","author":"Zeng","year":"2025","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.tox.2025.154359_bib231","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2025.154359_bib232","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jcpt.13006","article-title":"Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis","volume":"44","author":"Zhang","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2025.154359_bib233","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2017.07.003","article-title":"Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response","volume":"112","author":"Zhang","year":"2017","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.tox.2025.154359_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117481","article-title":"Triptolide-induced acute liver injury and its mechanism with estradiol in regulating macrophage-mediated inflammation and hepatocyte function","volume":"180","author":"Zhang","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.tox.2025.154359_bib235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1039\/C6TX00245E","article-title":"Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a (1)H NMR based metabolomics approach","volume":"6","author":"Zhao","year":"2017","journal-title":"Toxicol. Res (Camb. )"},{"key":"10.1016\/j.tox.2025.154359_bib236","article-title":"Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study","volume":"26","author":"Zhao","year":"2020","journal-title":"Med Sci. Monit."},{"key":"10.1016\/j.tox.2025.154359_bib237","article-title":"Predicting Antituberculosis Drug-Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study","volume":"9","author":"Zhong","year":"2021","journal-title":"JMIR Med Inf."},{"key":"10.1016\/j.tox.2025.154359_bib238","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1093\/nar\/gkz169","article-title":"Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tox.2025.154359_bib239","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jtv.2024.05.006","article-title":"Laponite\/lactoferrin hydrogel loaded with eugenol for methicillin-resistant Staphylococcus aureus-infected chronic skin wound healing","volume":"33","author":"Zhou","year":"2024","journal-title":"J. Tissue Viability"},{"key":"10.1016\/j.tox.2025.154359_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112799","article-title":"Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury","volume":"139","author":"Zhou","year":"2024","journal-title":"Int Immunopharmacol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X2500318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X2500318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:04:06Z","timestamp":1773875046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X2500318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":240,"alternative-id":["S0300483X2500318X"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2025.154359","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in antituberculosis drug-induced liver injury: Molecular mechanisms, genetic insights, and emerging animal-free prediction models","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2025.154359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154359"}}